Minor
NXP900 · Advanced Cancers
Enrollment closed, study ongoing
Nuvectis Pharma, Inc.Phase 1 NCT05873686 Registry history of NCT05873686 on ClinicalTrials.gov (opens the registry)
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Enrollment closed, study ongoing
Nuvectis Pharma, Inc.Phase 1 NCT05873686 Registry history of NCT05873686 on ClinicalTrials.gov (opens the registry)
| Phase 1 | 3 |
Lung Cancer (3) · Non-Small Cell Lung Cancer (NSCLC) (3) · Kidney Cancer (1) · Mesothelioma (1)